Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Localized Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02111187
What this trial is testing

A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14
Testing effectiveness (Phase 2)Ended earlyNCT00924807
What this trial is testing

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Medical Center 4
Not applicableActive Not RecruitingNCT03312972
What this trial is testing

Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

Who this might be right for
Locally Recurrent Prostate Cancer
Loyola University 50
Testing effectiveness (Phase 2)Ended earlyNCT04030559
What this trial is testing

Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

Who this might be right for
ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+14 more
University of California, Davis 11
Large-scale testing (Phase 3)Active Not RecruitingNCT02799706
What this trial is testing

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 885
Not applicableStudy completedNCT06372704
What this trial is testing

Is the HIFEM Procedure an Effective Treatment for Men With Post-prostatectomy Incontinence?

Who this might be right for
Prostate CancerIncontinencePelvic Floor Muscle Weakness
Kirsehir Ahi Evran Universitesi 27
Testing effectiveness (Phase 2)Ended earlyNCT03886493
What this trial is testing

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7
Early research (Phase 1)Active Not RecruitingNCT06703437
What this trial is testing

Long Acting Neuraxial Peri-prostatic Block in Cancer

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 12
Not applicableLooking for participantsNCT04831983
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors

Who this might be right for
Prostate Cancer
University of Milano Bicocca 30
Large-scale testing (Phase 3)Study completedNCT02175212
What this trial is testing

Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 362
Testing effectiveness (Phase 2)UnknownNCT06029036
What this trial is testing

A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Peking University First Hospital 53
Not applicableStudy completedNCT04307056
What this trial is testing

Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY

Who this might be right for
Prostate CancerUltrasound Therapy
Association Francaise d'Urologie 3,862
Not applicableNot Yet RecruitingNCT07407686
What this trial is testing

Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services

Who this might be right for
Prostate Cancer
Royal Marsden NHS Foundation Trust 100
Large-scale testing (Phase 3)Active Not RecruitingNCT02531516
What this trial is testing

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Who this might be right for
Prostatic Neoplasms
Aragon Pharmaceuticals, Inc. 1,503
Not applicableLooking for participantsNCT06270043
What this trial is testing

Focal Therapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Diego 500
Not applicableStudy completedNCT03162523
What this trial is testing

Experiences With HDR-brachytherapy in Norway

Who this might be right for
Prostate Cancer
Oslo University Hospital 325
Testing effectiveness (Phase 2)Active Not RecruitingNCT07335796
What this trial is testing

BMS986365 in Combination With Degarelix in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 7
Early research (Phase 1)Study completedNCT00099086
What this trial is testing

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 20
Not applicableLooking for participantsNCT07115992
What this trial is testing

Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%

Who this might be right for
Prostate CancerProstate Adenoma
Ruijin Hospital 270
Not applicableLooking for participantsNCT06362577
What this trial is testing

Clinical Study of HIFU for Localized Prostate Cancer

Who this might be right for
Localized Prostate Cancer
RenJi Hospital 60
Next Page